Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NXL is expected to report earnings to fall 9.09% to -10 cents per share on September 02
Q2'26
Est.
$-0.10
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.04
The last earnings report on May 08 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 45.10K shares outstanding, the current market capitalization sits at 7.44M.